1) Consequently, the rapid worldwide spread of AIDS has prompted an intense research effort to discover compounds that can effectively inhibit HIV. In the past two decades, twenty-five drugs, including nucleoside/nucleotide viral reverse transcriptase (RT) inhibitors (NRTIs), non-nucleoside RT inhibitors (NNRTIs), protease inhibitors (PIs), integrase inhibitor and fusion (or entry) inhibitors (FIs), were approved for clinical use in the world.
2) However, these drugs have only limited or transient clinical benefit due to their severe side effects and the emergence of viral variants resistant to HIV-1 inhibitors.
3) Therefore, the development of new, selective and safe HIV-1 inhibitors still remains a high priority for medical research. [4] [5] [6] [7] [8] Although a series of N-arylsulfonylindole derivatives were found to be potent and selective ligands for the human serotonin 5-HT 6 receptor, [9] [10] [11] to the best of our knowledge, little attention has been paid to the anti-HIV-1 activity of the single N-arylsulfonylindoles. In our previous paper, we have synthesized some single Narylindoles and benzyl phenyl ethers evaluated as HIV-1 inhibitors, and found some compounds demonstrated significant anti-HIV-1 activity. 12, 13) In continuation of our program aimed at the discovery and development of bioactive molecules, [12] [13] [14] [15] [16] [17] [18] herein we report the synthesis and anti-HIV-1 activity of some single N-arylsulfonylindoles bearing various functional groups. Furthermore, the preliminary structureactivity relationships (SARs) were also discussed.
Results and Discussion
Synthesis of N-Arylsulfonylindoles 3a-l N-Arylsulfonylindoles 3a-l ( Fig. 1) were synthesized as shown in Chart 1. Arylsulfonyl chlorides (1) reacted with indoles (2) in the presence of NaOH and triethylbenzylammonium chloride (TEBA) under ultrasonic irradiation at 40°C, and compounds 3a-l were obtained in 83-99% yields and identified by satisfactory 1 H-NMR and mass spectra. Anti-HIV-1 Activity of N-Arylsulfonylindoles 3a-l Compounds 3a-l were evaluated in vitro for their inhibitory activity against HIV-1 replication in acutely infected C8166 cells. 3Ј-Azido-3Ј-deoxythymidine (AZT) was used as a positive control. As shown in Table 1 27 , respectively. Interestingly, the anti-HIV-1 activities of many N-arylsulfonylindoles were more potent than those of our previously reported N-arylindoles and benzyl phenyl ethers. For example, the TI value of 3h was more than 22 times of that of N-(2-nitrophenyl)indole (TIϭ24.61), which exhibited the highest anti-HIV-1 activity of eight synthesized N-arylindoles, while the EC 50 value of 3h was significantly decreased 30 times compared with N-(2-nitrophenyl)indole (EC 50 ϭ7.88 mg/ml).
12) Similarly, the TI value of 3h was nearly 30 times of that of 4-nitrobenzyl phenyl ether (TIϭ18.32), which exhibited the highest anti-HIV-1 activity of ten synthesized benzyl phenyl ethers, while the EC 50 value of 3h was significantly decreased 23 times compared with 4-nitrobenzyl phenyl ether (EC 50 ϭ5.96 mg/ ml). 13) As it can be seen in Table 1 , it was possible to draw some structure-activity relationships from the comparative study. Firstly, it was shown that the electronic effect of substituted groups on the N-arylsulfonylindoles was related to anti-HIV-1 activity. For example, the EC 50 and TI values of 3b and 3f were 11.38/1.03 mg/ml, and Ͼ17.57/121.61, respectively; the EC 50 and TI values of 3c and 3g were 24.73/1.69 mg/ml, and Ͼ8.08/Ͼ118.34, respectively; the EC 50 and TI values of 3d and 3h were 3.00/0.26 mg/ml, and 26.01/543.78, respectively. Accordingly, the TI value of 3f was nearly 7 times of that of 3b; the TI value of 3g was more than 14 times of that of 3c; the TI value of 3h was nearly 21 times of that of 3d. That is, introducing electron-withdrawing group (e.g., nitro group) on the benzenesulfonyl ring, would give compound possessing more potent anti-HIV-1 activity than the corresponding one having electron-donating group (e.g., methyl group) (3f vs. 3b; 3g vs. 3c; 3h vs. 3d). The same results were also found on 3i (having nitro group on the benzenesulfonyl ring), and 3j or 3k (having methyl or ethyl group on the benzenesulfonyl ring), for example, the TI values of 3i, 3j and 3k were Ͼ270.27, Ͼ14.94, and 19.05, respectively. On the contrary, when the electron-withdrawing group (e.g., nitro group) was introduced on the indole's ring of 3j to give 3a, the anti-HIV-1 activity of which was decreased as compared with 3j. For example, the EC 50 and TI values of 3a and 3j were 26.31/13.38 mg/ml, and Ͼ6.68/Ͼ14.94, respectively. While the electron-donating group (e.g., methyl group) introduced on the 6-position of the indole's ring of 3j to give more potent compound 3d (TIϾ14.94 for 3j vs. TIϭ26.01 for 3d).
In the meantime, it was found that the position of methyl group on the indole's ring was very important to anti-HIV-1 activity of the corresponding compound. (1) When the methyl group was introduced on the 3-or 6-position of the indole's ring of 3j to yield more potent compounds 3b and 3d, the corresponding EC 50 and TI values of which were 11.38/3.00 mg/ml, and Ͼ17.57/26.01, respectively; however, when the methyl group was introduced on the 4-position of the indole's ring of 3j to yield less potent compound 3c (TIϾ14.94 for 3j vs. TIϾ8.08 for 3c). (2) When the methyl group was introduced on the 3-or 4-position of the indole's ring of 3i, the corresponding compound 3f or 3g showed the less potent anti-HIV-1 activity than 3i (TIϾ270.27 for 3i vs. TIϭ121.61 for 3f or TIϾ118.34 for 3g); but when the methyl group was introduced on the 6-position of the indole's ring of 3i, the corresponding compound 3h showed the more potent anti-HIV-1 activity than 3i, for example, the EC 50 and TI values of 3i and 3h were 0.74/0.26 mg/ml, and Ͼ270.27/543.78, respectively.
Consequently, based upon the above investigation, the nitro group on the benzenesulfonyl ring and the methyl group on the 6-position of the indole's ring certainly were two important functional groups for 3h being good HIV-1 inhibitory activity. Additionally, in order to find more potent molecules containing these kind structures, the mechanisms of the anti-HIV-1 function of these compounds need to be studied further.
Conclusion
In conclusion, twelve simple N-arylsulfonylindoles were synthesized and preliminarily evaluated as HIV-1 inhibitors in vitro. Six compounds 3d, 3f, 3g, 3h, 3i and 3l demonstrated significant anti-HIV-1 activity. Especially compounds 3h and 3i showed the highest anti-HIV-1 activity with EC 50 values of 0.26 and 0.74 mg/ml, and TI values of 543.78 and Ͼ270.27, respectively.
Experimental
General All the solvents were of analytical grade and the reagents were used as purchased. Thin-layer chromatography (TLC) and preparative thinlayer chromatography (PTLC) were performed with silica gel plates using silica gel 60 GF 254 (Qingdao Haiyang Chemical Co., Ltd.). Melting points were determined on a digital melting-point apparatus and were uncorrected. Ningbo SB-5200DT ultrasonic cleaner with the frequency of 40 kHz and an output power of 200 W.
General Procedure for the Synthesis of N-Arylsulfonylindoles 3a-l The mixture of arylsulfonyl chlorides (1, 0.55 mmol), indoles (2, 0.5 mmol), NaOH (0.875 mmol), and triethylbenzylammonium chloride (TEBA, 0.05 mmol) in dichloromethane (2 ml) in 25 ml round-bottomed flask was reacted under ultrasonic irradiation at 40°C. When the reaction was complete according to TLC analysis, the reaction mixture was filtered, and the filtrate was concentrated in vacuo and purified by PTLC to give the pure Narylsulfonylindoles.
N 
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MTT-Based Cytotoxicity Assay Cellular toxicity of compounds 3a-l on C8166 cells was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method as described previously. 26) Briefly, cells were seeded on 96-well microtiter plate in the absence or presence of various concentrations of compounds in triplicate and incubated at 37°C in a humid atmosphere of 5% CO 2 for 3 d. The supernatants were discarded and MTT reagent (5 mg/ml in PBS) was added to each well, then incubated for 4 h, 100 ml of 50% N,N-dimethylformamide (DMF)-20% SDS was added. After the formazan was dissolved completely, the plates were read on a BioTek Elx 800 ELISA reader at 595/630 nm. The cytotoxic concentration that caused the reduction of viable C8166 cells by 50% (CC 50 ) was determined from dose-response curve.
Syncytia Assay In the presence of 100 ml various concentrations of compounds, C8166 cells (4ϫ10 5 /ml) were infected with virus HIV-1 IIIB at a multiplicity of infection (M.O.I) of 0.06. The final volume per well was 200 ml. Control assays were performed without the testing compounds in HIV-1 IIIB infected and uninfected cultures. After 3 d of culture, the cytopathic effect (CPE) was measured by counting the number of syncytia. Percentage inhibition of syncytia formation was calculated and 50% effective concentration (EC 50 ) was calculated. AZT (Sigma) was used as a positive control. Therapeutic index (TI)ϭCC 50 /EC 50 . 27) 
